Reijers, I L M, Rao, D, Versluis, J M, Menzies, A M, Dimitriadis, P, Wouters, M W, Spillane, A J, Klop, W M C, Broeks, A, Bosch, L J W, Lopez-Yurda, M, van Houdt, W J, Rawson, R V, Grijpink-Ongering, L G, Gonzalez, M, Cornelissen, S, Bouwman, J, Sanders, J, Plasmeijer, E, Elshot, Y S, Scolyer, R A, van de Wiel, B A, Peeper, D S, van Akkooi, A C J, Long, G V & Blank, C U 2023, ' IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma ', Journal of Experimental Medicine, vol. 220, no. 5, e20221952 . https://doi.org/10.1084/jem.20221952 Journal of experimental medicine, 220(5):e20221952. Rockefeller University Press Journal of Experimental Medicine, 220(5):e20221952. Rockefeller University Press
Haematologica, 106(4), 1129-1137. Ferrata Storti Foundation Haematologica, 106, 1129-1129 Haematologica Kersten, M J, Driessen, J, Zijlstra, J M, Plattel, W J, Morschhauser, F, Lugtenburg, P J, Brice, P, Hutchings, M, Gastinne, T, Liu, R, Burggraaff, C N, Nijland, M, Tonino, S H, Arens, A I J, Valkema, R, van Tinteren, H, Lopez-Yurda, M, Diepstra, A, De Jong, D & Hagenbeek, A 2021, ' Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma : the phase II HOVON/LLPC Transplant BRaVE study ', Haematologica, vol. 106, no. 4, pp. 1129-1137 . https://doi.org/10.3324/haematol.2019.243238 Haematologica, 106(4), 1129-1136. FERRATA STORTI FOUNDATION Haematologica, 106, 4, pp. 1129-1129